Sign In
Buy MDWD
$13.73
-0.0300 (-0.218%)
At Close: Jun 03, 2026
MediWound Ltd. (MDWD) CEO Sharon Malka on Q3 2021 Results - Earnings Call Transcript
04:50pm, Tuesday, 16'th Nov 2021 Seeking Alpha
The Daily Biotech Pulse: Kezar Jumps On Data, Biogen R&D Chief To Retire, Molecular Partners Wilts On COVID Trial Disappointment
01:30pm, Tuesday, 16'th Nov 2021 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours:
Stocks In Focus
Kezar Life Sciences Reports Positive Interim Phase 2 Data For Lupus Nephritis Treatment Candidate
Keza
MediWound (MDWD) Reports Q3 Loss, Tops Revenue Estimates
01:15pm, Tuesday, 16'th Nov 2021 Zacks Investment Research
MediWound (MDWD) delivered earnings and revenue surprises of 0.00% and 13.79%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
MediWound Ltd. (MDWD) CEO Sharon Malka on Q3 2021 Results - Earnings Call Transcript
11:50am, Tuesday, 16'th Nov 2021
MediWound Ltd. (MDWD) CEO Sharon Malka on Q3 2021 Results - Earnings Call Transcript
MediWound (MDWD) Reports Q3 Loss, Tops Revenue Estimates
10:00am, Tuesday, 16'th Nov 2021
MediWound (MDWD) delivered earnings and revenue surprises of 0.00% and 13.79%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview For MediWound
10:30am, Monday, 15'th Nov 2021
MediWound (NASDAQ:MDWD) is set to give its latest quarterly earnings report on Tuesday, 2021-11-16. Here's what investors need to know before the announcement.
The Week Ahead In Biotech (Nov. 14-Nov. 20): BioMarin FDA Decision, Tapering Earnings News Flow, Conference Presentations And More
02:57pm, Sunday, 14'th Nov 2021 Benzinga
Biotech stocks declined for the second straight week amid a broader market pullback, along with earnings news from small- and micro-cap companies and presentations at multiple conferences.
Among the
MediWound Announces Peer-Reviewed Publication of EscharEx In-Vivo Head-to-Head Comparator Study in the Journal of Wound Care
07:30am, Monday, 04'th Oct 2021
EscharEx Treatment Demonstrated Superior Efficacy in Debridement of Eschar EscharEx Treatment Demonstrated Superior Efficacy in Debridement of Eschar
MediWound to Present at Upcoming Investor Conferences
04:14pm, Friday, 03'rd Sep 2021
YAVNE, Israel, Sept. 03, 2021 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD) (the “Company”), a fully-integrated biopharmaceutical company focused on next-generation biotherapeutic solutions fo
Mediwound Ltd (MDWD) CEO Sharon Malka on Q2 2021 Results - Earnings Call Transcript
05:09pm, Tuesday, 10'th Aug 2021
Mediwound Ltd (MDWD) CEO Sharon Malka on Q2 2021 Results - Earnings Call Transcript
MediWound (MDWD) Reports Q2 Loss, Tops Revenue Estimates
10:07am, Tuesday, 10'th Aug 2021
MediWound (MDWD) delivered earnings and revenue surprises of -9.09% and 6.36%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
MediWound Reports Second Quarter Financial Results
07:00am, Tuesday, 10'th Aug 2021
Second Quarter Revenues of $6.1 Million - Increase of 50% Year-over-Year
MediWound to Report Second Quarter 2021 Financial Results and Host a Conference Call and Webcast on August 10, 2021
04:05pm, Monday, 02'nd Aug 2021
YAVNE, Israel, Aug. 02, 2021 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), a fully integrated biopharmaceutical company focused on next-generation bio-therapeutic solutions for tissue repair and
MediWound: Disappointing Thus Far But Still A Strong Buy
06:00am, Friday, 30'th Jul 2021
MediWound: Disappointing Thus Far But Still A Strong Buy
